Regression of solid tumors by induction of MazF, a bacterial mRNA endoribonuclease

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• MazF from Escherichia coli is an endoribonuclease that targets specific mRNA sequences.
• MazF induction in mammalian cells can trigger programmed cell death.
• Toxin-antitoxin systems are bacterial elements with potential biotechnological applications.

Purpose of the Study:

• To investigate the potential of the bacterial MazF-MazE toxin-antitoxin system for cancer gene therapy.
• To evaluate the efficacy of MazF induction in regressing solid tumors in a preclinical model.

Main Methods:

• Construction of a tetracycline-inducible MazF expression system in human embryonic kidney cells (T-Rex 293-mazF).
• Inoculation of nude mice with T-Rex 293-mazF cells to establish solid tumors.
• Monitoring tumor regression upon induction of MazF expression and assessing the role of the antitoxin MazE.

Main Results:

• Induction of MazF led to the regression of solid tumors in all injected mice.
• Complete tumor regression was observed in 50% of the mice, while the others experienced tumor regrowth due to loss of functional MazF.
• Expression of the antitoxin MazE counteracted the tumor-regressing effect of MazF.

Conclusions:

• The bacterial MazF-MazE system demonstrates potential as a therapeutic tool for cancer gene therapy.
• MazF-mediated tumor regression is feasible, but maintaining functional MazF expression is critical for sustained efficacy.
• The antitoxin MazE plays a crucial role in regulating MazF activity, highlighting the importance of the toxin-antitoxin balance in therapeutic applications.